Loading...

BrainsWay Ltd.

BWAY•NASDAQ
Healthcare
Medical - Devices
$16.37
$0.62(3.94%)
U.S. Market opens in 30h 27m

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap642.1M
P/E Ratio39.34
EPS (TTM)$0.18
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$23.28
3 Months$26.73
1 Year Target$28.87

BWAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BWAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 39.34 and a market capitalization of 642.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.94%
5-Day Change
5.61%
1-Month Change
21.26%
3-Month Change
42.10%
6-Month Change
94.65%
Year-to-Date (YTD) Change
72.13%
1-Year Change
258.99%
3-Year Change
1985.35%
5-Year Change
268.69%
All-Time (Max) Change
194.95%

Contact Information

https://www.brainsway.com
972 2 582 4030
Bynet Building, Jerusalem, NaN, 9777518

Company Facts

120 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions